A 43-year-old male patient presented to our hospital on November 27, 2024, with “a 4-year history of Hepatic Dysfunction (HD).” On April 28, 2020, the patient was examined at the Taizhou Enze Medical Center (Group) and exhibited elevated levels of Alanine Aminotransferase (ALT; 84 U/L↑), Aspartate Aminotransferase (AST; 54 U/L↑), γ-Glutamyl Transpeptidase (GGT; 88 U/L↑), α-L-fucosidase (AFU; 84 U/L↑), and Alpha-Fetoprotein (AFP; 10.3 ng/ml↑). This evidence concerns the gene GPT and Huntington disease.